0001209191-19-009273.txt : 20190212
0001209191-19-009273.hdr.sgml : 20190212
20190212160540
ACCESSION NUMBER: 0001209191-19-009273
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190208
FILED AS OF DATE: 20190212
DATE AS OF CHANGE: 20190212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Invesco Ltd.
CENTRAL INDEX KEY: 0000914208
STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282]
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36754
FILM NUMBER: 19590771
BUSINESS ADDRESS:
STREET 1: 1555 PEACHTREE STREET NE
STREET 2: SUITE 1800
CITY: ATLANTA
STATE: GA
ZIP: 30309
BUSINESS PHONE: 404-892-0896
MAIL ADDRESS:
STREET 1: 1555 PEACHTREE STREET NE
STREET 2: SUITE 1800
CITY: ATLANTA
STATE: GA
ZIP: 30309
FORMER NAME:
FORMER CONFORMED NAME: Invesco Ltd
DATE OF NAME CHANGE: 20080508
FORMER NAME:
FORMER CONFORMED NAME: Invesco PLC
DATE OF NAME CHANGE: 20080429
FORMER NAME:
FORMER CONFORMED NAME: Invesco Ltd.
DATE OF NAME CHANGE: 20071205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evofem Biosciences, Inc.
CENTRAL INDEX KEY: 0001618835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208527075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 550-1900
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Neothetics, Inc.
DATE OF NAME CHANGE: 20140905
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-08
0
0001618835
Evofem Biosciences, Inc.
EVFM
0000914208
Invesco Ltd.
1555 PEACHTREE STREET NE
SUITE 1800
ATLANTA
GA
30309
0
0
1
0
Common stock
2019-02-08
4
P
0
425531
2.64
A
9590688
I
See Footnote
Warrants
5.20
2019-02-08
4
P
0
212765
0.0001
A
2026-02-08
Common Stock
212765
212765
I
see footnote
Invesco Ltd. is the beneficial owner of 9,590,688 shares of common stock and warrants to purchase 212,765 common shares acquired by its affiliates, Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund.
The warrants are exercisable on the earlier of 08/08/2019, or following the date that the issuance of the warrants is approved by the stockholders of the Issuer.
Nancy Tomassone, Global Assurance Officer
2019-02-12